Global Health Limited (NSE:MEDANTA)
India · Delayed Price · Currency is INR 1,439.90
+10.90 (0.76%)
Nov 12, 2026, 3:29 PM IST
Global Health Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Global Health stock has a consensus rating of "Strong Buy" and an average price target of ₹1,652. The average 1-year stock price forecast is 14.74% higher than the current stock price, while the lowest is ₹1,510 (+4.87%) and the highest is ₹1,830 (+27.09%).
Price Target: ₹1,652 (+14.74%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 4, 2026.
Analyst Ratings
The average analyst rating for Global Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 10 | 11 | 11 | 11 |
| Buy | 4 | 4 | 6 | 6 | 6 | 7 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 18 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹1,500 → ₹1,660 | Buy | Maintains | ₹1,500 → ₹1,660 | +15.29% | Aug 4, 2026 |
Financial Forecast
Revenue This Year
55.51B
from 44.10B
Increased by 25.86%
Revenue Next Year
63.19B
from 55.51B
Increased by 13.83%
EPS This Year
28.69
from 20.69
Increased by 38.66%
EPS Next Year
35.01
from 28.69
Increased by 22.05%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.